Bill > SB00011

This bill is a comprehensive legislative effort to increase access to affordable prescription drugs and healthcare in Connecticut through multiple strategies. The bill establishes a Prescription Drug Affordability Council to advise on drug negotiations, creates mechanisms to limit prescription drug prices by preventing pharmaceutical manufacturers from selling drugs above a specific reference price, and imposes civil penalties for non-compliance. It also expands emergency Medicaid coverage for various medical conditions, increases asset limits for the HUSKY C health program, and requires health insurers to provide coverage for diabetes-related treatments with reduced out-of-pocket costs. Additionally, the bill explores the feasibility of importing prescription drugs from Canada, establishes a task force to study prescription drug shortages, and requires pharmacy benefits managers to act with a fiduciary duty to health carriers. Other notable provisions include creating an advisory committee for vaccine production coordination, expanding emergency Medicaid coverage, and mandating reporting on health carrier and pharmacy benefits manager pricing practices. The bill aims to make healthcare more affordable and accessible by addressing various aspects of drug pricing, insurance coverage, and healthcare service delivery.

Budget and Finance, Health and Social Services, Justice

Human Services Committee (J)

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00011&which_year=2025